公开(公告)号：US12251365B2

公开(公告)日：2025-03-18

申请号：US16684874

申请日：2019-11-15

Applicant: AbbVie Inc.

Inventor： Ehab Moussa ,  Matthew Rosebraugh ,  Feroz Jameel ,  Nancy Sever ,  Maurizio F. Facheris ,  Weining Z Robieson ,  Charles S. Locke ,  Sven Stodtmann

IPC: A61P25/16 ,  A61K9/00 ,  A61K31/198 ,  A61K31/661

Abstract: The present disclosure relates to compositions of levodopa 4′-monophosphate and carbidopa 4′-monophosphate having a weight by weight ratio of about 20:1 and methods of treating Parkinson's disease and associated conditions by subcutaneous administration of such compositions.

公开(公告)号：US20190029951A1

公开(公告)日：2019-01-31

申请号：US16073042

申请日：2017-01-31

Applicant: AbbVie Inc.

Inventor： Hao Xiong ,  Alyssa E. Debord ,  Philip Komarnitsky ,  Silpa Nuthalapati ,  Sven Stodtmann

IPC: A61K9/00 ,  A61K31/4184 ,  A61P35/00

Abstract: Described herein are extended release formulations of veliparib, ways to make them, and methods of treating cancer using them.

公开(公告)号：US20200155578A1

公开(公告)日：2020-05-21

申请号：US16684874

申请日：2019-11-15

Applicant: AbbVie Inc.

Inventor： Ehab Moussa ,  Matthew Rosebraugh ,  Feroz Jameel ,  Nancy Sever ,  Maurizio F. Facheris ,  Weining Z. Robieson ,  Charles S. Locke ,  Sven Stodtmann

IPC: A61K31/661 ,  A61K9/00 ,  A61P25/16

Abstract: The present disclosure relates to compositions of levodopa 4′-monophosphate and carbidopa 4′-monophosphate having a weight by weight ratio of about 20:1 and methods of treating Parkinson's disease and associated conditions by subcutaneous administration of such compositions.